Rapidly Fatal Multiple Organ Failure of Intravenous Amiodarone: A Case Report and Literature Review

We present the case of a patient who developed multiorgan failure and died following the intravenous administration of amiodarone. This suggests that it is critical to evaluate the status of patients to choose amiodarone as first-line medication. Patients should be continuously monitored for hemodynamics and organ function during short-term intravenous administration. In cases of high suspicion, the drug should be discontinued promptly, and organ functional recovery should be performed.